Dynamic contrast???enhanced (DCE) MRI imaging biomarker in Phase I study with imatinib (I) and cisplatin (C) plus docetaxel (D) in patients with advanced non???small cell lung cancer (NSCLC): P3-154
Journal of Thoracic Oncology(2007)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要